Miyagawa-Hayashino A - Search Results

1

Arteriopathy in chronic allograft rejection in liver transplantation.

Miyagawa-Hayashino A, Tsuruyama T, Haga H, Oike F, Il-Deok K, Egawa H, Hiai H, Tanaka K, Manabe T. Miyagawa-Hayashino A, et al. Liver Transpl. 2004 Apr;10(4):513-9. doi: 10.1002/lt.20081. Liver Transpl. 2004. PMID: 15048794 Free article.

2

Novel surrogate end-point biomarker to evaluate agents for use in the chemoprevention of reactive oxygen species-associated cancer.

Hiroyasu M, Ozeki M, Miyagawa-Hayashino A, Fujiwara Y, Hiai H, Toyokuni S. Hiroyasu M, et al. Redox Rep. 2002;7(5):335-8. doi: 10.1179/135100002125000938. Redox Rep. 2002. PMID: 12688524 Free article.

3

De novo autoimmune hepatitis affecting allograft but not the native liver in auxiliary partial orthotopic liver transplantation.

Miyagawa-Hayashino A, Haga H, Sakurai T, Shirase T, Manabe T, Egawa H. Miyagawa-Hayashino A, et al. Transplantation. 2003 Jul 15;76(1):271-2. doi: 10.1097/01.TP.0000072338.88465.59. Transplantation. 2003. PMID: 12865828 No abstract available.

4

Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.

Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, Tanaka K, Manabe T. Miyagawa-Hayashino A, et al. Transplantation. 2004 Jul 15;78(1):128-35. doi: 10.1097/01.tp.0000132328.33460.43. Transplantation. 2004. PMID: 15257051

5

Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation.

Tanaka Y, Haga H, Egawa H, Okuno T, Miyagawa-Hayashino A, Tsuruyama T, Kambe M, Marusawa H, Chiba T, Manabe T. Tanaka Y, et al. Liver Transpl. 2005 May;11(5):547-54. doi: 10.1002/lt.20415. Liver Transpl. 2005. PMID: 15838883 Free article.

6

Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.

Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, Okuno T, Koyanagi I, Takada Y, Manabe T. Haga H, et al. Liver Transpl. 2006 Mar;12(3):457-64. doi: 10.1002/lt.20652. Liver Transpl. 2006. PMID: 16498648 Free article.

7

B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.

Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A, Oike F, Fukuda A, Yoshizawa J, Takada Y, Tanaka K, Maekawa T, Ozawa K, Uemoto S. Egawa H, et al. Liver Transpl. 2007 Apr;13(4):579-88. doi: 10.1002/lt.21092. Liver Transpl. 2007. PMID: 17394164 Free article.

8

Significance of C4d staining in ABO-identical/compatible liver transplantation.

Sakashita H, Haga H, Ashihara E, Wen MC, Tsuji H, Miyagawa-Hayashino A, Egawa H, Takada Y, Maekawa T, Uemoto S, Manabe T. Sakashita H, et al. Mod Pathol. 2007 Jun;20(6):676-84. doi: 10.1038/modpathol.3800784. Epub 2007 Apr 13. Mod Pathol. 2007. PMID: 17431411 Free article.

9

FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.

Miyagawa-Hayashino A, Tsuruyama T, Egawa H, Haga H, Sakashita H, Okuno T, Toyokuni S, Tamaki K, Yamabe H, Manabe T, Uemoto S. Miyagawa-Hayashino A, et al. Am J Pathol. 2007 Nov;171(5):1499-508. doi: 10.2353/ajpath.2007.070027. Epub 2007 Sep 6. Am J Pathol. 2007. PMID: 17823283 Free PMC article.

10

Histological recurrence of autoimmune liver diseases after living-donor liver transplantation.

Haga H, Miyagawa-Hayashino A, Taira K, Morioka D, Egawa H, Takada Y, Manabe T, Uemoto S. Haga H, et al. Hepatol Res. 2007 Oct;37 Suppl 3:S463-9. doi: 10.1111/j.1872-034X.2007.00245.x. Hepatol Res. 2007. PMID: 17931204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters